查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2086160

骨生物製藥市場：2026-2032年全球市場預測（依產品類型、製劑類型、作用機制、手術方法、應用、最終用戶及通路分類）

Osteobiologics Market by Product Type, Formulation Type, Mechanism of Action, Surgical Approach, Application, End-User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，骨生物製藥市場將成長至 132.2 億美元，複合年成長率為 5.79%。

主要市場統計數據
基準年 2025 89.1億美元
預計年份：2026年 94.2億美元
預測年份 2032 132.2億美元
複合年成長率 (%) 5.79%

隨著整形外科、脊椎外科、創傷外科、牙科和顱顎顏面生物製藥的外科醫生尋求能夠促進骨癒合、改善骨融合、填充骨缺損並減少自體骨採集依賴的骨移植替代方案，骨生物製劑市場正在擴大。主要產品類別包括同種異體骨移植、去礦骨基質、合成陶瓷、生物活性玻璃、骨形成蛋白（BMP）產品、細胞基質及血小板衍生生物製藥。

需求受可衡量的人口統計因素和臨床顯著因素所驅動。世界衛生組織（WHO）預測，到2030年，全球60歲以上人口將達到14億，到2050年將達到21億，這將導致骨質疏鬆症、椎間盤退化、脆性骨折、傷口癒合延遲和再次手術等疾病負擔加重。這些趨勢使得骨生物製藥成為再生整形外科醫學和骨再生技術領域至關重要的組成部分。

骨生物製藥領域的變革性變化

骨生物製藥領域正從傳統的自體移植治療轉向現成的、針對特定手術的生物製劑。醫院和外科醫生在評估骨生物製藥時，不僅關注產品創新，還越來越重視其在骨癒合性能、操作特性、無菌保證、安全性、醫保報銷適用性以及治療過程中的整體價值等方面的表現。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過改善患者分層、手術規劃、影像學檢查、植入適配性評估以及骨不連和骨不癒合的風險預測，正在生物製藥。 AI 驅動的分析使外科醫生能夠識別可能受益於強化生物支持的患者，尤其是在複雜的脊椎融合手術、創傷重組和整形外科翻修手術中。

對關鍵區域的洞察

隨著中國、印度、日本、韓國和澳洲加大對整形外科醫療體系、私人醫院基礎設施和本地醫療技術製造的投資，亞太地區骨科市場正蓬勃發展。日本和韓國人口老化、中國和印度創傷和退化性疾病高發，以及先進脊椎外科手術的普及，都推動了對骨生物製藥的持續需求。此外，醫療旅遊、專科培訓的拓展以及合成骨移植替代物的日益普及也對該地區產生了影響，其中成本、供應和品質穩定性是關鍵的採購因素。

主要群體分析

東協市場受益於醫療旅遊、私人醫院的擴張以及新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國整形外科手術數量的成長。海灣合作理事會（GCC）國家則受益於政府主導的醫院現代化、專業外科中心的建設以及對先進脊椎手術、創傷治療和牙科骨再生手術的需求。在這兩個市場中，產品的採用都取決於外科醫生的培訓水平、監管註冊所需時間、分銷商的能力以及在成本敏感的採購環境中證明臨床可靠性的能力。

主要國家的概況

美國在骨科手術的普及方面處於領先地位，這得益於其大量的脊椎、創傷、運動醫學、牙科和重組手術。在加拿大，重點在於循證採購、嚴格執行公共保險報銷以及省級醫療技術評估。墨西哥和巴西是拉丁美洲的重要中心，這得益於其私人醫院網路、整形外科培訓中心以及不斷擴大的複雜脊椎和​​創傷手術服務。

為行業領導者提供的實用建議

產業領導者應優先考慮針對特定手術（例如脊椎融合手術、骨折修復、齒槽骨再生和重新置換手術）量身定做的、具有臨床差異化的骨生物製藥製劑產品組合。相關證據應包括對比結果、真實世界臨床註冊數據、併發症追蹤、生技藥品安全監測以及能夠向外科醫生、支付方和醫院採購團隊證明其價值的衛生經濟學模型。

調查方法

本執行摘要基於系統的研究方法，該方法結合了二級研究、一級行業檢驗、監管調查方法、公開的臨床文獻、醫院採購趨勢、報銷標準以及世界衛生組織、經合組織、美國食品藥品監督管理局、歐洲藥品管理局和國家衛生當局等組織提供的公開資料集。

結論

隨著醫療保健機構應對人口老化、骨折和退化性疾病帶來的負擔、牙齒重組的需求以及對微創、高價值手術的需求，骨生物製藥在現代整形外科和脊椎醫學中正變得至關重要。只有當臨床證據、保險報銷管道、外科醫生信心、監管準備和穩定供應這三者齊備時，骨生物製劑的發展勢頭才能達到最大化。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：骨生物製藥市場：依產品類型分類

  • 骨移植替代物
    • 同種異體移植
      • 去礦物質骨基質
      • 礦化骨同種異體移植
      • 機械加工的同種異體骨移植
    • 合成骨移植材料
      • 磷酸鈣
      • 硫酸鈣
      • 聚合物基替代品
    • 異質骨移植
  • 骨形成蛋白
    • 重組BMP-2
    • 重組BMP-7
  • 細胞衍生基質
    • 間質幹細胞
    • 骨髓穿刺濃縮液
    • 脂肪來源幹細胞

第8章：骨生物製藥市場：依製劑類型分類

  • 油灰
  • 貼上
  • 顆粒
  • 凝膠

第9章：骨生物製藥市場：依作用機制分類

  • 骨傳導
  • 骨誘導
  • 成骨

第10章：骨骼生物製藥市場：依手術方法分類

  • 開放性手術
  • 微創手術

第11章 骨生物製藥市場：依應用領域分類

  • 脊椎固定
    • 頸椎融合術
    • 胸腰椎融合術
  • 創傷與肢體
    • 骨折修復
    • 四肢重建
  • 關節重組
    • 髖關節
    • 膝蓋
    • 肩膀
  • 運動傷害
  • 骨關節炎的骨科生技藥品
  • 顱顎顏面
    • 牙骨移植
    • 臉部重組

第12章 骨生物製藥市場：依最終用戶分類

  • 醫院
    • 民眾
    • 私人的
  • 整形外科診所
  • 門診手術中心
  • 牙醫診所
  • 研究和學術機構

第13章：骨生物製藥市場：依通路分類

  • 離線
  • 線上

第14章 骨生物製藥市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 骨生物製藥市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 骨生物製藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • AlloSource
  • Arthrex Inc
  • Baxter International Inc
  • Bioventus Inc
  • Bone Biologics Corporation
  • BoneSupport AB
  • Cerapedics Inc
  • DePuy Synthes
  • Exactech Inc
  • Geistlich Pharma AG
  • Globus Medical Inc
  • Integra LifeSciences Holdings Corporation
  • Isto Biologics
  • Kuros Biosciences AG
  • LifeNet Health, Inc.
  • Medtronic plc
  • NuVasive Inc
  • Orthofix Medical Inc
  • OssDsign AB
  • Ossio Ltd
  • Regenity Biosciences
  • SeaSpine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Xtant Medical Holdings Inc
  • Zimmer Biomet Holdings Inc
Product Code: MRR-036C5CF3B4C0

The Osteobiologics Market is projected to grow by USD 13.22 billion at a CAGR of 5.79% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.91 billion
Estimated Year [2026] USD 9.42 billion
Forecast Year [2032] USD 13.22 billion
CAGR (%) 5.79%

The osteobiologics market is advancing as orthopedic, spine, trauma, dental, and craniomaxillofacial surgeons seek bone graft substitutes that support bone healing, improve fusion, fill skeletal defects, and reduce dependence on autograft harvesting. Core product families include allografts, demineralized bone matrix, synthetic ceramics, bioactive glass, bone morphogenetic protein products, cell-based matrices, and platelet-derived biologic solutions.

Demand is supported by measurable demographic and clinical fundamentals. The World Health Organization reports that the global population aged 60 years and older is projected to reach 1.4 billion by 2030 and 2.1 billion by 2050, increasing the burden of osteoporosis, degenerative disc disease, fragility fractures, delayed unions, and revision procedures. These trends position osteobiologics as a critical segment of regenerative orthopedic medicine and bone regeneration technologies.

Transformative Shifts in the Osteobiologics Landscape

The osteobiologics landscape is shifting from traditional autograft-centric care toward off-the-shelf, procedure-specific biologic solutions. Hospitals and surgeons increasingly evaluate osteobiologics on fusion performance, handling characteristics, sterility assurance, safety profile, reimbursement fit, and total episode-of-care value rather than product innovation alone.

Transformative forces include stricter regulatory evidence expectations, wider use of minimally invasive spine surgery, additive manufacturing of porous scaffolds, and broader adoption of synthetic bone graft substitutes. EU Medical Device Regulation, FDA oversight of biologic-device combination products, tissue-bank standards, and hospital value analysis committees are reshaping product development, labeling, sourcing, and commercialization strategies across orthopedic biologics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating practical value across osteobiologics by improving patient stratification, procedure planning, imaging interpretation, implant-fit assessment, and prediction of nonunion or fusion failure risk. AI-enabled analytics can help surgeons identify patients who may benefit from enhanced biologic support, particularly in complex spine fusion, trauma reconstruction, and revision orthopedic procedures.

Beyond clinical decision support, AI accelerates materials discovery, scaffold design, manufacturing quality control, adverse-event monitoring, and supply forecasting for biologic and synthetic graft portfolios. Adoption must remain evidence-led, with validated datasets, cybersecurity safeguards, bias management, and clear accountability under evolving FDA, EMA, and institutional AI governance frameworks.

Key Regional Insights

Asia-Pacific is gaining momentum as China, India, Japan, South Korea, and Australia invest in orthopedic capacity, private hospital infrastructure, and local medtech manufacturing. Aging populations in Japan and South Korea, large trauma and degenerative disease pools in China and India, and improving access to advanced spine surgery support durable osteobiologics demand. The region is also influenced by medical tourism, expanding specialist training, and increasing use of synthetic bone graft substitutes where cost, availability, and consistency are key purchasing factors.

North America remains the most mature adoption environment due to high surgical volumes, established orthopedic and spine networks, advanced reimbursement pathways, and rapid uptake of premium spine biologics in the United States and Canada. Europe is shaped by MDR compliance, evidence generation, national procurement controls, and strong clinical governance, while Latin America relies heavily on Brazil and Mexico for advanced orthopedic access. The Middle East, led by GCC hospital investment and specialty care expansion, is moving toward advanced spine and trauma centers, whereas Africa shows longer-term potential tied to trauma care, urban hospital expansion, workforce development, and improved access to surgical infrastructure.

Key Group Insights

ASEAN markets benefit from medical tourism, expanding private hospitals, and growing orthopedic procedure volumes in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is driven by government-backed hospital modernization, specialist surgery centers, and demand for advanced spine, trauma, and dental bone regeneration procedures. Across both groups, adoption depends on surgeon training, regulatory registration timelines, distributor capability, and the ability to demonstrate clinical reliability in cost-sensitive procurement environments.

The European Union is defined by harmonized but more demanding regulatory compliance under MDR, which favors products supported by strong clinical evidence, traceable sourcing, and post-market surveillance. BRICS markets offer scale, localization incentives, and rising surgical access across China, India, Brazil, Russia, and South Africa, while G7 countries remain leading adopters of high-value osteobiologics due to mature hospital infrastructure and evidence-based purchasing. NATO member markets collectively emphasize supply resilience, quality assurance, procurement transparency, and alignment with advanced regulatory and healthcare security standards.

Key Country Insights

The United States leads adoption through large spine, trauma, sports medicine, dental, and reconstructive procedure volumes, while Canada emphasizes evidence-based purchasing, public reimbursement discipline, and provincial health technology assessment. Mexico and Brazil are important Latin American anchors, supported by private hospital networks, orthopedic training centers, and expanding access to complex spine and trauma surgery.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging populations with strong orthopedic infrastructure, clinical registries, and demand for validated bone graft substitutes, while Russia remains influenced by localization priorities and procurement constraints. China and India provide large long-term procedural opportunity through expanding surgical access and hospital investment. Japan and South Korea lead in advanced clinical adoption supported by aging demographics, sophisticated spine practices, and high standards for product quality, while Australia combines strong public-private healthcare delivery with uptake of evidence-backed osteobiologics in orthopedic, dental, and trauma applications.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated osteobiologics portfolios that match specific procedures, including spinal fusion, fracture repair, dental bone regeneration, and revision arthroplasty. Evidence generation should include comparative outcomes, real-world registry data, complication tracking, biologic safety monitoring, and health-economic models that demonstrate value to surgeons, payers, and hospital procurement teams.

Companies should strengthen supply-chain resilience, tissue sourcing transparency, surgeon education, and regulatory readiness across FDA, EU MDR, and local market requirements. Partnerships with hospitals, academic centers, and AI analytics providers can accelerate product validation, while regional manufacturing or distribution alliances can improve access in high-growth Asia-Pacific, GCC, ASEAN, and BRICS markets.

Research Methodology

This executive summary is built on a structured research methodology that triangulates secondary research, primary industry validation, regulatory review, public clinical literature, hospital procurement trends, reimbursement references, and public datasets from organizations such as WHO, OECD, FDA, EMA, and national health authorities.

The analysis evaluates demand drivers, product innovation, procedure adoption, regional health-system capacity, regulatory dynamics, reimbursement patterns, tissue safety standards, and competitive positioning without relying on market sizing, market share, or forecasting. Findings are validated through cross-source consistency checks and market-factor mapping to ensure insights remain data-backed, commercially relevant, and suitable for strategic decision-making in the osteobiologics industry.

Conclusion

Osteobiologics are becoming essential to modern orthopedic and spine care as providers manage aging populations, fracture burden, degenerative disease, dental reconstruction needs, and demand for less invasive, higher-value surgery. Momentum is strongest where clinical evidence, reimbursement access, surgeon confidence, regulatory readiness, and reliable supply converge.

Future leadership will depend on procedure-specific innovation, disciplined regulatory execution, AI-enabled decision support, and demonstrable patient outcomes. Organizations that combine validated bone regeneration technologies with regional access strategies, transparent sourcing, and value evidence will be best positioned to build sustainable relevance in the global osteobiologics landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Osteobiologics Market, by Product Type

  • 7.1. Bone Graft Substitutes
    • 7.1.1. Allografts
      • 7.1.1.1. Demineralized Bone Matrix
      • 7.1.1.2. Mineralized Bone Allografts
      • 7.1.1.3. Machined Allografts
    • 7.1.2. Synthetic Bone Grafts
      • 7.1.2.1. Calcium Phosphate
      • 7.1.2.2. Calcium Sulfate
      • 7.1.2.3. Polymer-based Substitutes
    • 7.1.3. Xenografts
  • 7.2. Bone Morphogenetic Proteins
    • 7.2.1. Recombinant BMP-2
    • 7.2.2. Recombinant BMP-7
  • 7.3. Cell-Based Matrices
    • 7.3.1. Mesenchymal Stem Cells
    • 7.3.2. Bone Marrow Aspirate Concentrates
    • 7.3.3. Adipose-Derived Stem Cells

8. Osteobiologics Market, by Formulation Type

  • 8.1. Putty
  • 8.2. Paste
  • 8.3. Granules
  • 8.4. Gel

9. Osteobiologics Market, by Mechanism of Action

  • 9.1. Osteoconductive
  • 9.2. Osteoinductive
  • 9.3. Osteogenic

10. Osteobiologics Market, by Surgical Approach

  • 10.1. Open Surgery
  • 10.2. Minimally Invasive Surgery

11. Osteobiologics Market, by Application

  • 11.1. Spinal Fusion
    • 11.1.1. Cervical Fusion
    • 11.1.2. Thoracolumbar Fusion
  • 11.2. Trauma & Extremities
    • 11.2.1. Fracture Repair
    • 11.2.2. Limb Reconstruction
  • 11.3. Joint Reconstruction
    • 11.3.1. Hip
    • 11.3.2. Knee
    • 11.3.3. Shoulder
  • 11.4. Sports Injuries
  • 11.5. Orthobiologics for Osteoarthritis
  • 11.6. Craniomaxillofacial
    • 11.6.1. Dental Bone Grafting
    • 11.6.2. Facial Reconstruction

12. Osteobiologics Market, by End-User

  • 12.1. Hospitals
    • 12.1.1. Public
    • 12.1.2. Private
  • 12.2. Orthopedic Clinics
  • 12.3. Ambulatory Surgical Centers
  • 12.4. Dental Clinics
  • 12.5. Research & Academic Institutes

13. Osteobiologics Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Osteobiologics Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Osteobiologics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Osteobiologics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. AlloSource
  • 18.2. Arthrex Inc
  • 18.3. Baxter International Inc
  • 18.4. Bioventus Inc
  • 18.5. Bone Biologics Corporation
  • 18.6. BoneSupport AB
  • 18.7. Cerapedics Inc
  • 18.8. DePuy Synthes
  • 18.9. Exactech Inc
  • 18.10. Geistlich Pharma AG
  • 18.11. Globus Medical Inc
  • 18.12. Integra LifeSciences Holdings Corporation
  • 18.13. Isto Biologics
  • 18.14. Kuros Biosciences AG
  • 18.15. LifeNet Health, Inc.
  • 18.16. Medtronic plc
  • 18.17. NuVasive Inc
  • 18.18. Orthofix Medical Inc
  • 18.19. OssDsign AB
  • 18.20. Ossio Ltd
  • 18.21. Regenity Biosciences
  • 18.22. SeaSpine Holdings Corporation
  • 18.23. Smith & Nephew plc
  • 18.24. Stryker Corporation
  • 18.25. Xtant Medical Holdings Inc
  • 18.26. Zimmer Biomet Holdings Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL OSTEOBIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL OSTEOBIOLOGICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MINERALIZED BONE ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MINERALIZED BONE ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MINERALIZED BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MACHINED ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MACHINED ALLOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MACHINED ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SYNTHETIC BONE GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SYNTHETIC BONE GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SYNTHETIC BONE GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CALCIUM SULFATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CALCIUM SULFATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CALCIUM SULFATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYMER-BASED SUBSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYMER-BASED SUBSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYMER-BASED SUBSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL XENOGRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL XENOGRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL XENOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RECOMBINANT BMP-2 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RECOMBINANT BMP-2 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RECOMBINANT BMP-2 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RECOMBINANT BMP-7 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RECOMBINANT BMP-7 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RECOMBINANT BMP-7 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CELL-BASED MATRICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL-BASED MATRICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CELL-BASED MATRICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BONE MARROW ASPIRATE CONCENTRATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE MARROW ASPIRATE CONCENTRATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BONE MARROW ASPIRATE CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ADIPOSE-DERIVED STEM CELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ADIPOSE-DERIVED STEM CELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ADIPOSE-DERIVED STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PUTTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PUTTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PUTTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PASTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PASTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PASTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GRANULES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OSTEOCONDUCTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OSTEOCONDUCTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OSTEOCONDUCTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OSTEOINDUCTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OSTEOINDUCTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL OSTEOINDUCTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OSTEOGENIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OSTEOGENIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OSTEOGENIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPINAL FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPINAL FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPINAL FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CERVICAL FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CERVICAL FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CERVICAL FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL THORACOLUMBAR FUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL THORACOLUMBAR FUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL THORACOLUMBAR FUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TRAUMA & EXTREMITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TRAUMA & EXTREMITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TRAUMA & EXTREMITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FRACTURE REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FRACTURE REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FRACTURE REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL LIMB RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL LIMB RECONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL LIMB RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HIP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HIP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL KNEE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL KNEE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL KNEE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SHOULDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SHOULDER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SHOULDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SPORTS INJURIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SPORTS INJURIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SPORTS INJURIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ORTHOBIOLOGICS FOR OSTEOARTHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ORTHOBIOLOGICS FOR OSTEOARTHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ORTHOBIOLOGICS FOR OSTEOARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CRANIOMAXILLOFACIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL CRANIOMAXILLOFACIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CRANIOMAXILLOFACIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DENTAL BONE GRAFTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DENTAL BONE GRAFTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DENTAL BONE GRAFTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FACIAL RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FACIAL RECONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FACIAL RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. GCC OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 288. GCC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. GCC OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 290. GCC OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 291. GCC OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 292. GCC OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 293. GCC OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 294. GCC OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. GCC OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 296. GCC OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 297. GCC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. GCC OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 299. GCC OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 300. GCC OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 301. GCC OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 302. GCC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 303. GCC OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 304. GCC OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 318. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. BRICS OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 332. BRICS OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 333. BRICS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 334. BRICS OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 335. BRICS OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 336. BRICS OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 337. BRICS OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 338. BRICS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 339. BRICS OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 340. BRICS OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 341. G7 OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. G7 OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. G7 OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 344. G7 OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 345. G7 OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 346. G7 OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 347. G7 OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 348. G7 OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 349. G7 OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 350. G7 OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 351. G7 OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 352. G7 OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 353. G7 OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 354. G7 OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 355. G7 OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2018-2032 (USD MILLION)
  • TABLE 356. G7 OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 357. G7 OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 358. G7 OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 359. NATO OSTEOBIOLOGICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 360. NATO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 361. NATO OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 362. NATO OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2018-2032 (USD MILLION)
  • TABLE 363. NATO OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 364. NATO OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2018-2032 (USD MILLION)
  • TABLE 365. NATO OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2018-2032 (USD MILLION)
  • TABLE 366. NATO OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 367. NATO OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 368. NATO OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 369. NATO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 370. NATO OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2018-2032 (USD MILLION)
  • TABLE 371. NATO OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2018-2032 (USD MILLION)
  • TABLE 372. NATO